Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997

Bishara, Jihad; Pitlik, Silvio; Samra, Zmira; Levy, Itzhak; Paul, Mical; Leibovici, Leonard

doi:10.3201/eid0909.020666

i

Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997

Supporting Files Public Domain

Sep 2003
By Bishara, Jihad ; Pitlik, Silvio ; Samra, Zmira ; ...

Details

Alternative Title:

Emerg Infect Dis
Personal Author:

Bishara, Jihad ; Pitlik, Silvio ; Samra, Zmira ; Levy, Itzhak ; Paul, Mical ; Leibovici, Leonard
Description:

Among bloodstream methicillin-resistant Staphylococcus aureus (MRSA) isolates from adult patients in a single hospital, susceptibility to co-trimoxazole increased progressively from 31% in 1988 to 92% in 1997 (p<0.0001). If also observed in other institutions, these findings should encourage the performance of a clinical trial of sufficient size to compare co-trimoxazole to vancomycin in treating MRSA infections.
Subjects:

Adult Anti-Bacterial Agents Co-Trimoxazole Cross Infection Dispatch Humans Israel Methicillin Methicillin Resistance Microbial Sensitivity Tests Nosocomial Resistance Staphylococcal Infections Staphylococcus Aureus Susceptibility
Source:

Emerg Infect Dis. 9(9):1168-1169.
Document Type:

Journal Article
Volume:

9
Issue:

9
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

urn:sha256:0926a4a0c08172143ac595508b96345db0014438f8ed7fc9abce6e617af4a6f7
Download URL:

https://stacks.cdc.gov/view/cdc/14150/cdc_14150_DS1.pdf
File Type:

[PDF - 174.92 KB ]

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.